Randall Simpson JA, Keller HH, Rysdale LA, Beyers JE. Nutrition screening tool for every preschooler (NutriSTEP): validation and test-retest reliability of a parent-administered questionnaire assessing nutrition risk of preschoolers. Eur J Clin Nutr 2008;62:770–80.Google Scholar
Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997;337:869–73.Google Scholar
American Diabetic Association. ADA’s definitions for nutrition screening and nutrition assessment. J Am Diet Assoc 1994;94:838–9.Google Scholar
NIH Technology Assessment Conference Panel. Methods for voluntary weight loss and control. Ann Intern Med 1993;119:764–70.Google Scholar
Jääskeläinen P, Magnussen CG, Pahkala K, Mikkilä V, Kähönen M, et al. Childhood nutrition in predicting metabolic syndrome in adults: the cardiovascular risk in Young Finns Study. Diabetes Care 2012;35:1937–43.Google Scholar
Katzmarzyk PT, Pérusse L, Malina RM, Bergeron J, Després JP, et al. Stability of indicators of the metabolic syndrome from childhood and adolescence to young adulthood: the Québec Family Study. J Clin Epidemiol 2001;54:190–5.Google Scholar
Watson-Jarvis K, McNeil D, Fenton TR, Campbell K. Implementing the nutrition screening tool for every preschooler (NutriSTEP) in community health centres. Can J Diet Pract Res 2011;72:96–8.Google Scholar
Persaud N, Maguire JL, Lebovic G, Carsley S, Khovratovich M, et al. Association between serum cholesterol and eating behaviours during early childhood: a cross-sectional study. Can Med Assoc J 2013;185:E531–6.Google Scholar
Wilasco MI, Goldani HA, Dornelles CT, Maurer RL, Kieling CO, et al. Ghrelin, leptin and insulin in healthy children: relationship with anthropometry, gender, and age distribution. Regul Pept 2012;173:21–6.Google Scholar
Zhang YY, Proenca R, Maffei M, Barone M, Leopold L, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425–32.Google Scholar
Morrison CD. Leptin signaling in brain: a link between nutrition and cognition? Biochim Biophys Acta 2009;1792:401–8.Google Scholar
Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med 2002;346:570–8.Google Scholar
Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404:661–71.Google Scholar
Hamnvik OP, Liu X, Petrou M, Gong H, Chamberland JP, et al. Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: the Cyprus Metabolism Prospective Cohort Study. Metabolism 2011;60:987–93.Google Scholar
Savoye M, Dziura J, Castle J, DiPietro L, Tamborlane WV, et al. Importance of plasma leptin in predicting future weight gain in obese children: a two-and-a-half-year longitudinal study. Int J Obes Relat Metab Disord 2002;26:942–6.Google Scholar
Mansoub S, Chan MK, Adeli K. Gap analysis of pediatric reference intervals for risk biomarkers of cardiovascular disease and the metabolic syndrome. Clin Biochem 2006; 39:569–87.Google Scholar
Burke GL, Webber LS, Srinivasan SR, Radhakrishnamurthy B, Freedman DS, et al. Fasting plasma glucose and insulin levels and their relationship to cardiovascular risk factors in children: Bogalusa Heart Study. Metabolism 1986;35:441–6.Google Scholar
Jiang X, Srinivasan SR, Bao W, Berenson GS. Association of fasting insulin with blood pressure in young individuals. The Bogalusa Heart Study. Arch Intern Med 1993;153:323–8.Google Scholar
Chu NF, Wang DJ, Shieh SM, Rimm EG. Plasma leptin concentrations and obesity in relation to insulin resistance syndrome components among school children in Taiwan–The Taipei Children Heart Study. Int J Obes Relat Metab Disord 2000;24:1265–71.CrossrefGoogle Scholar
Marquina D, Peña R, Fernández E, Baptista T. Abnormal correlation between serum leptin levels and body mass index may predict metabolic dysfunction irrespective of the psychopharmacological treatment. Int Clin Psychopharmacol 2011;26:169–72.Google Scholar
Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell 1996;87:377–89.Google Scholar
Havel PJ. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med 2001;126:963–77.Google Scholar
Statistics Canada. Canadian Community Health Survey-Annual Component (CCHS). Available at http://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&SDDS=3226. Accessed on 6/2/2014.
Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000;356:279–84.Google Scholar
Balarajan R. Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. Br Med J 1991;302:560–4.Google Scholar
World Health Organization. Training course on child growth assessment. Available at: www.who.int/childgrowth/training/module_c_interpreting_indicators.pdf. Accessed on 25/11/2013.
Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York (NY): Springer Science, 2001:48–9;56–60.Google Scholar
Little RJ, Rubin DB. Statistical analysis with missing data. 2nd ed. Hoboken, NJ: Wiley, 2002:41–53;66–70;85–9.Google Scholar
Al-Daghri N, Al-Rubean K, Bartlett WA, Al-Attas O, Jones AF, et al. Serum leptin is elevated in Saudi Arabian patients with metabolic syndrome and coronary artery disease. Diabet Med 2003;20:832–7.Google Scholar
Moreno LA, Pineda I, Rodríguez G, Fleta J, Giner A, et al. Leptin and metabolic syndrome in obese and non-obese children. Horm Metab Res 2002;34:394–9.Google Scholar
Schoppen S, Riestra P, García-Anguita A, López-Simón L, Cano B, et al. Leptin and adiponectin levels in pubertal children: relationship with anthropometric variables and body composition. Clin Chem Lab Med 2010;48:707–11.CrossrefGoogle Scholar
Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995;377:530–2.Google Scholar
Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002;110:1093–103.Google Scholar
Farooqi IS, O’Rahilly S. Leptin: a pivotal regulator of human energy homeostasis. Am J Clin Nutr 2009;89:980S–4S.Google Scholar
Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997;46:2040–3.Google Scholar
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415–28.Google Scholar
Wedick NM, Snijder MB, Dekker JM, Heine RJ, Stehouwer CD, et al. Prospective investigation of metabolic characteristics in relation to weight gain in older adults: the Hoorn Study. Obesity 2009;17:1609–14.CrossrefGoogle Scholar
Baskin DG, Figlewicz Lattemann D, Seeley RJ, Woods SC, Porte D Jr, et al. Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res 1999;848:114–23.Google Scholar
Ilett S, Freeman A. Improving the diet of toddlers of Pakistani origin: a study of intensive dietary health education. J Fam Health Care 2004;14:16–9.Google Scholar
Wyse R, Wolfenden L, Campbell E, Campbell W, Brennan L, et al. A pilot study of a telephone-based parental intervention to increase fruit and vegetable consumption in 3–5-year-old children. Public Health Nutr 2011;14:2245–53.CrossrefGoogle Scholar
Yukuwa M, Phelan EA, Callahan HS, Spiekerman CF, Abrass IB, et al. Leptin levels recover normally in healthy older adults after acute diet-induced weight loss. J Nutr Health Aging 2008;12:652–6.Google Scholar
Anderson PJ, Critchley JA, Chan JC, Cockram CS, Lee ZS, et al. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int J Obes Relat Metab Disord 2001;25:1782–8.CrossrefGoogle Scholar
DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173–94.CrossrefGoogle Scholar
Gil-Campos M, Aguilera CM, Ramirez-Tortosa MC, Cañete R, Gil A. Fasting and post-prandial relationships among plasma leptin, ghrelin, and insulin in prepubertal obese children. Clin Nutr 2010;29:54–9.Google Scholar
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292–5.Google Scholar
Ruige JB, Dekker JM, Blum WF, Stehouwer CD, Nijpels G, et al. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care 1999;22:1097–104.CrossrefGoogle Scholar
About the article
Published Online: 2017-07-19
Published in Print: 2017-08-28
Author contributions: All of the authors made substantial contributions to the conception and design of the study; the acquisition, analysis and interpretation of the data; and the drafting of the manuscript or its critical revision for important intellectual content. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This work was supported by the Canadian Institute of Health Research, Physician Services Incorporated, Paediatric Outcomes Research Team through the SickKids Foundation, and St. Michael’s Hospital Foundation (grant number MOP-119375). The funding agencies had no role in the design, analysis or writing of this article.
Employment or leadership: Navindra Persaud is an Associate Editor for CMAJ. Janis Randall Simpson has received grant funding from the Canadian Institutes of Health Research (CIHR); she is a board member for the Danone Institute of Canada; she is a consultant for Dietitians of Canada; she receives royalties for NutriSTEP© licences; and she has been reimbursed for travel expenses by the CIHR. Brian McCrindle is a board member for Medpace; he has been a consultant for Eli Lilly, Merck and Bristol-Myers-Squibb; and he has received grant funding from AstraZeneca. Patricia Parkin and Catherine Birken work for institutions that have received grants from the CIHR. No other competing interests were declared. The other authors have no financial relationships relevant to this article to declare.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.